Back to search

University of Edinburgh

Role of human cyclophilins in coronavirus infection

Abstract

dc:description.abstract

BACKGROUND: Seven coronaviruses are known to infect humans. Four of them, HCoV-229E, HCoV-NL63, HCoV-OC43, and HCoV-HKU1, typically cause mild, seasonal respiratory infections. In contrast, the other three—SARS-CoV, MERS-CoV, and SARS-CoV-2—are associated with more severe disease. The COVID-19 pandemic was caused by the SARS-CoV-2 virus, which has affected and resulted in the deaths of millions globally. The human genome has 16 unique cyclophilins. These proteins are essential for several cellular activities, including protein folding and transport, maintaining receptor complex stability, regulating apoptosis, modulating immune responses, and RNA degradation. They also facilitate muscle growth and eliminate reactive oxygen species (ROS). Increasing evidence indicates that cyclophilins are associated with viral infections. Cyclophilins directly interact with viral proteins, enabling viruses to evade the immune system and modulating the body's response to viral infections. Research involving animals and cell cultures has demonstrated that both immunosuppressive and non-immunosuppressive cyclophilin inhibitors may reduce viral replication. OBJECTIVE: The objective of this study is to demonstrate that GFP fluorescence is an effective method for monitoring the active replication of coronaviruses within cultured cells. This study examines the efficacy of non-immunosuppressive cyclophilin inhibitors in inhibiting the replication of HCoV-229E in vitro. The Cellular Thermal Shift Assay (CETSA) has been employed to confirm target engagement and determine the EC₅₀ values of cyclophilin inhibitors for Cyclophilin A (CypA) and mitochondrial Cyclophilin D (CypD) in treated cells. The study examined how cyclophilin inhibitors inhibit the replication of the coronavirus. This study examined the interaction between human cyclophilin A and other SARS-CoV-2 proteins to further aid the understanding of viral replication inhibition. Finally, we utilized a nanopore amplicon based nanopore sequencing protocol for whole genome sequencing of HCoV-229E. This enabled us to identify mutations and determine if they are associated with the phenotypic changes observed during virus culture. METHODS: In this study, we used different techniques including molecular cloning, tissue culture, nanopore sequencing, co-immunoprecipitation and bioinformatics to achieve the objectives mentioned. RESULTS AND CONCLUSION: This study showed that GFP fluorescence is an effective marker to quantify HCoV-229E replication in cell culture in real time, and it was strongly correlated with N-gene expression. We used this marker to study a compound library of novel non-immunosuppressive cyclophilin inhibitors. We discovered a few compounds that inhibit HCoV-229E replication in cell culture with minimal cytotoxicity. Furthermore, we demonstrated that these compounds target coronavirus replication at entry and post-entry phases on virus replication. We also discovered that recombinant cyclophilin A enhances HCoV-229E replication at both entry and post entry stages of virus replication. CETSA assay was developed to test intracellular target engagement of non-immunosuppressive cyclophilin inhibitors with cyclophilin A and mitochondrial cyclophilin D and EC50 values were calculated for both proteins. Nanopore whole-genome sequencing of HCoV-229E mutants revealed mutations in NSP4, NSP13, and the EGFP reporter. These mutations enhanced virus replication and GFP fluorescence. We also observed that several cyclophilin isoforms are secreted in the media of transfected cells, including the PPIA, PPIB, PPIC, PPIE and PPIH. This shows that they have roles in virus-host interactions outside of cells. These discoveries help us understand more about how coronaviruses function, reveal that cyclophilins are effective targets for antiviral compounds, and provide us with a great tool to understand how viruses interact with their hosts, how treatments work, and how viruses evolve over time during subsequent culture in the lab.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Elhabyan, Abdelazeem Abdelhameed
Advisors dc:contributor.advisor
  • Haas, Juergen
  • Walkinshaw, Malcolm
  • Makrantoni
  • Makrantoni, Vaso

Subjects

dc:subject × 7

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Elhabyan, Abdelazeem Abdelhameed. Role of human cyclophilins in coronavirus infection. 2026. https://era.ed.ac.uk/handle/1842/44520